Taysha Gene Therapies, Inc. logo TSHA - Taysha Gene Therapies, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY
0
BUY 15
HOLD 3
SELL 0
STRONG
SELL
0
| PRICE TARGET: $14.00 DETAILS
HIGH: $15.00
LOW: $13.00
MEDIAN: $14.00
CONSENSUS: $14.00
UPSIDE: 155.47%
Metric 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4
Revenue
Revenue 0 0 5.5 0 2.0 2.3 2.0 1.8 1.1 3.4 3.6 4.7 2.4 4.7 2.5 0 0 0 0 0 0 0 0 0 0 0 0
Cost of Revenue 0 0.3 0.3 0.3 0 0 0 0 0 0 0 0.3 0.7 0.6 1.7 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit 0 (0.3) 5.2 (0.3) 2.0 2.3 2.0 1.8 1.1 3.4 3.6 4.4 1.7 4.1 0.8 0 0 0 0 0 0 0 0 0 0 0 0
Operating Expenses
R&D Expenses 38.6 33.8 24.7 25.5 20.1 15.6 15.3 14.9 15.1 20.7 12.7 11.8 19.8 12.5 13.9 16.8 23.5 38.2 37.9 39.5 30.6 23.9 12.3 11.1 3.1 5.5 1.0
SG&A Expenses 12.1 9.7 8.8 8.3 8.6 8.2 6.6 7.9 7.3 7.1 6.7 8.3 5.3 8.1 5.7 8.7 9.9 11.5 11.8 11.2 10.1 8.2 6.1 4.0 0.9 0.1 0.1
Other Expenses (3.4) (0.3) 0 0 0 0 0 4.8 0 0 0.4 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Expenses 47.3 43.2 33.5 33.7 28.7 23.7 22.0 27.7 22.4 27.7 19.9 20.0 25.1 20.6 19.5 25.5 33.4 49.7 49.7 50.7 40.8 32.1 18.4 15.0 4.0 5.6 1.1
Operating Income
Operating Income (47.3) (43.5) (28.3) (34.0) (26.8) (21.4) (19.9) (25.9) (21.3) (24.3) (16.2) (15.6) (23.4) (16.6) (18.7) (25.5) (33.4) (49.7) (49.7) (50.7) (40.8) (32.1) (18.4) (15.0) (4.0) (5.6) (1.1)
Interest Expense 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.5 1.4 1.4 0.8 1.1 0.7 0.7 0.7 0.5 0.2 0 0 0.0 0 0.0 0
Interest Income 2.3 2.6 2.9 3.2 1.9 1.3 1.7 2.1 1.4 1.7 1.9 1.1 0.2 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0 0 0 0
Profitability
EBITDA (46.2) (42.1) (28.0) (32.4) (26.6) (21.2) (18.5) (25.2) (20.6) (23.7) 48.8 (115.3) (22.5) (15.6) (53.2) (25.2) (33.1) (49.4) (49.5) (50.5) (40.6) (32.0) (18.3) (15.0) (21.2) (5.4) (1.1)
EBIT (46.6) (42.4) (28.3) (32.7) (26.9) (21.5) (18.8) (25.5) (20.9) (24.0) 48.5 (115.6) (23.2) (16.2) (54.9) (25.4) (33.3) (49.6) (49.7) (50.6) (40.7) (32.0) (18.3) (15.0) (21.2) (5.4) (1.1)
Income Before Tax (46.6) (42.4) (27.9) (32.7) (26.9) (21.5) (18.8) (25.5) (20.9) (24.1) 47.7 (117.1) (24.6) (17.6) (55.7) (26.5) (34.1) (50.3) (50.4) (51.2) (40.9) (32.0) (18.3) (15.0) (21.2) (5.4) (1.1)
Income Tax Expense 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Income (46.6) (42.4) (27.9) (32.7) (26.9) (21.5) (18.8) (25.5) (20.9) (24.1) 47.7 (117.1) (24.6) (17.6) (55.7) (26.5) (34.1) (50.3) (50.4) (51.2) (40.9) (32.0) (18.3) (15.0) (21.2) (5.4) (1.1)
Per Share Data
EPS (Basic) -0.13 -0.12 -0.08 -0.09 -0.09 -0.08 -0.09 -0.10 -0.09 -0.10 0.26 -0.93 -0.38 -0.28 -0.99 -0.65 -0.85 -1.32 -1.32 -1.35 -1.09 -0.87 -0.49 -1.28 -0.61 -0.36 -0.07
EPS (Diluted) -0.13 -0.12 -0.08 -0.09 -0.09 -0.08 -0.09 -0.10 -0.09 -0.10 0.26 -0.93 -0.38 -0.28 -0.99 -0.65 -0.85 -1.32 -1.32 -1.35 -1.09 -0.87 -0.49 -1.28 -0.61 -0.36 -0.07
Shares Outstanding 369.0 366.6 319.7 353.3 298.0 269.3 204.9 267.8 232.8 231.2 187.0 125.7 64.2 63.3 56.4 40.9 40.1 38.2 38.1 38.0 37.5 37.0 37.8 11.7 34.5 15.2 15.2
Metric 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2
Current Assets
Cash & Cash Equivalents 455.4 276.6 319.8 297.3 312.8 116.6 139.0 157.7 172.7 124.0 143.9 164.3 45.1 63.4 87.9 34.3 66.2 96.6 149.1 188.8 197.4 228.7 251.3 278.6 11.2
Short-Term Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Receivables 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Inventory 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Current Assets 0 1.7 1.4 1.8 1.1 1.1 0.9 0.9 3.3 3.3 3.4 3.1 5.7 6.0 1.2 6.3 7.5 7.3 6.6 1.2 1.0 7.2 2.8 0 0.1
Total Current Assets 461.4 282.2 324.6 300.0 316.3 120.7 142.1 161.6 178.5 130.6 149.9 171.8 54.1 72.4 96.4 43.0 76.8 106.9 159.6 197.2 207.3 239.6 257.9 279.2 11.3
Non-Current Assets
Property, Plant & Equipment 8.7 15.6 16.2 14.3 14.7 15.3 15.9 16.3 19.5 19.9 20.4 21.0 24.5 25.3 25.9 64.0 61.0 55.1 50.6 40.6 33.9 2.5 0.3 0.0 0.0
Goodwill 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Intangible Assets 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Long-Term Investments 0 0 2.3 0 0 0 0 0 0 0 0 0 2.6 2.6 0 2.6 2.6 2.6 2.6 0 0 0 0 0 0
Other Non-Current Assets 0.3 2.5 0.2 2.3 2.3 2.3 2.4 2.4 2.4 2.5 2.5 2.9 0.3 1.3 4.0 1.9 1.8 1.3 1.1 3.3 0.7 0.7 0.7 0 0
Total Non-Current Assets 9.0 18.1 18.7 16.6 17.1 17.7 18.2 18.7 21.9 22.4 22.9 24.0 27.4 29.2 29.9 68.5 65.5 59.1 54.4 43.9 34.6 3.2 1.0 0.0 0.0
Total Assets 470.4 300.4 343.3 316.6 333.3 138.4 160.4 180.2 200.4 153.0 172.7 195.8 81.5 101.6 126.3 111.5 142.3 166.0 214.0 241.0 241.9 242.8 258.9 279.3 11.3
Current Liabilities
Account Payables 9.2 4.6 6.3 5.4 7.7 4.3 3.6 4.9 8.7 10.4 6.4 7.5 10.8 9.0 10.9 15.3 24.0 22.0 21.8 22.1 6.4 4.1 2.0 8.8 1.2
Short-Term Debt 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 17.2
Deferred Revenue 0 0 0 0 5.5 7.5 9.8 11.8 13.6 14.7 18.1 18.8 20.2 28.9 33.6 0 0 0 0 0 0 0 0 0 0
Other Current Liabilities 0 15.5 10.9 7.1 5.5 3.7 6.4 5.3 4.3 3.2 5.0 145.0 15.9 13.6 4.6 3.2 2.7 3.1 4.1 6.5 3.9 1.2 0.3 0.8 0
Total Current Liabilities 26.0 20.1 26.6 28.6 25.3 22.6 26.2 29.3 34.2 38.6 36.8 180.5 50.6 54.5 62.8 33.1 43.0 48.6 51.7 43.2 28.4 19.0 7.1 11.6 20.1
Non-Current Liabilities
Long-Term Debt 49.3 17.8 18.2 50.9 41.1 42.5 43.9 43.0 37.8 40.5 40.5 38.5 38.4 38.2 38.0 37.8 37.6 37.4 37.2 27.8 0 0 0 0 0
Deferred Tax Liabilities 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 1.6 50.5 51.7 1.5 1.4 1.2 1.3 1.4 1.4 1.5 1.6 3.8 3.9 4.0 4.1 3.9 3.5 3.5 3.7 3.0 0.8 1.0 0.5 0 0
Total Non-Current Liabilities 57.2 68.3 69.8 68.9 59.3 60.7 62.6 62.1 57.3 60.5 61.0 64.4 68.0 62.1 62.5 67.2 66.7 66.6 66.8 57.4 27.0 1.0 0.5 0 0
Total Liabilities 83.2 88.4 96.4 97.6 84.6 83.3 88.8 91.4 91.5 99.2 97.8 244.9 118.7 116.5 125.3 100.3 109.6 115.3 118.6 100.6 55.4 20.0 7.6 11.6 20.1
Stockholders' Equity
Common Stock 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0 0 0 0 0 0 0 0
Retained Earnings (800.3) (753.7) (711.3) (683.4) (650.7) (623.8) (602.3) (583.5) (558.0) (537.1) (513.0) (560.7) (443.7) (419.1) (401.4) (345.9) (319.6) (285.8) (235.6) (185.3) (134.1) (93.2) (61.1) (42.8) (27.8)
Accumulated Other Comprehensive Income 0.8 1.0 (0.2) (1.1) (0.7) (2.3) (4.0) (2.3) 2.4 (0.3) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Total Stockholders' Equity 387.3 211.9 246.9 219.0 248.7 55.1 71.5 88.8 108.9 53.8 74.9 (49.1) (37.1) (14.9) 0.9 11.1 32.7 50.7 95.4 140.4 186.5 222.9 251.3 267.6 (8.8)
Total Liabilities & Equity 470.4 300.4 343.3 316.6 333.3 138.4 160.4 180.2 200.4 153.0 172.7 195.8 81.5 101.6 126.3 111.5 142.3 166.0 214.0 241.0 241.9 242.8 258.9 279.3 11.3
Debt Metrics
Total Debt 55.6 17.8 18.2 69.1 59.6 61.4 63.2 62.5 57.7 60.7 61.1 59.2 59.5 59.8 59.9 63.3 63.2 63.1 63.1 54.4 26.2 0 0 0 17.2
Net Debt (399.9) (258.8) (301.6) (228.3) (253.2) (55.2) (75.9) (95.2) (115.0) (63.3) (82.8) (105.1) 14.4 (3.6) (28.0) 29.0 (3.0) (33.5) (86.0) (134.4) (171.2) (228.7) (251.3) (278.6) 6.0
Metric 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4
Operating Activities
Net Income (46.6) (42.4) (27.9) (32.7) (26.9) (21.5) (18.8) (25.5) (20.9) (24.1) 47.7 (117.1) (24.6) (17.6) (55.7) (26.5) (34.1) (50.3) (50.4) (51.2) (40.9) (32.0) (18.3) (15.0) (21.2) (5.4) (1.1)
Depreciation & Amortization 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.4 0.3 0.3 0.3 0.4 0.3 0.3 0.3 0.2 0.2 0.1 0.0 0.0 0.0 0 0 0
Stock-Based Compensation 5.8 5.5 3.5 3.3 3.2 3.3 3.2 3.4 3.3 3.2 2.0 2.0 2.2 1.7 4.1 4.5 4.1 5.3 5.0 5.1 4.5 3.6 2.0 1.3 0 0 0
Change in Working Capital 4.8 (4.7) (7.1) 4.0 2.2 (4.6) (2.6) (5.9) (4.3) 0.3 (4.8) (7.4) (0.8) (5.0) 27.5 (7.6) (4.2) 2.0 2.0 12.5 13.3 0.9 (6.5) 4.0 1.5 0.9 0.1
Other Non-Cash Items (4.7) 0.3 4.4 1.0 1.0 0.5 (0.4) 6.1 0.1 0.4 (57.4) 3.1 4.1 0.4 38.0 0.6 0.5 1.8 2.9 1.5 0.2 5.5 3 3 17.2 2.8 1.0
Operating Cash Flow (40.4) (40.9) (26.7) (24.2) (20.2) (22.0) (18.3) (21.6) (21.5) (19.8) (16.1) (17.9) (18.8) (20.2) 14.3 (28.8) (33.4) (40.9) (40.3) (31.9) (22.8) (22.0) (19.8) (6.7) (2.5) (1.7) 0
Investing Activities
Capital Expenditure 0.0 (3.0) (0.2) (0.1) (0.0) (0.4) 0.0 (0.0) (0.2) (0.1) (0.0) (3.5) 0.0 (3.9) (2.3) (3.0) (8.1) (11.4) (8.5) (4.0) (8.5) (0.5) (6.1) (0.0) 0 0 0
Acquisitions 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Purchases of Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Sales/Maturities of Investments 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Investing Activities 0 (3) 0.0 0.1 0.1 0.0 0.0 0 0 0 0.0 0.0 0 0 (0.1) (1) (0.2) (3) (0.2) (0.5) (5.5) 0 (6) 0 (3) 0 0
Investing Cash Flow 0.0 (3.0) (0.2) (0.0) 0.1 (0.4) 0.0 (0.0) (0.2) (0.1) (0.0) (3.5) 0.0 (3.9) (2.4) (3.0) (8.1) (11.4) (8.5) (4.0) (8.5) (0.5) (6.1) (0.0) (3) 0 0
Financing Activities
Net Debt Issuance 0 0 0 0 0 0 0 0 0 0 (3.8) 0 0 0 0 0 0 0 10.0 30.0 0 0 0 (0.0) 0.0 0.0 0
Stock Repurchased 0 0 0 (0.2) 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 0.1 0.0 (0.1) 9.0 0.1 (0.1) 0.0 (0.1) (0.0) (0.0) 0.0 (0.1) 0.4 (0.4) 0.1 (0.1) 11.1 (0.1) (0.9) 0 0 0 (95.8) 167.4 (0.3) 0 0
Financing Cash Flow 216.7 0.7 49.6 8.8 216.3 (0.1) (0.4) 6.6 70.5 (0.0) (4.2) 140.6 0.4 (0.4) 41.7 (0.1) 11.1 (0.1) 9.1 30.0 0 0 (1.5) 274.2 0.3 18.0 0
Cash Position
Net Change in Cash 176.2 (43.2) 22.6 (15.4) 196.2 (22.4) (18.7) (15.1) 48.8 (20.0) (20.4) 119.2 (18.3) (24.5) 53.6 (31.9) (30.4) (52.5) (39.7) (6.0) (31.3) (22.6) (27.4) 267.4 (5.1) 16.3 0
Cash at Beginning 279.3 320.2 299.9 315.4 119.2 141.6 160.3 175.3 126.6 146.5 166.9 47.7 66.1 90.5 36.9 68.9 99.3 151.7 191.4 197.4 228.7 251.3 278.6 11.2 16.3 0 0
Cash at End 455.6 277.0 322.5 299.9 315.4 119.2 141.6 160.3 175.3 126.6 146.5 166.9 47.7 66.1 90.5 36.9 68.9 99.3 151.7 191.4 197.4 228.7 251.3 278.6 11.2 16.3 0
Free Cash Flow (40.4) (43.9) (27.0) (24.3) (20.2) (22.4) (18.3) (21.6) (21.7) (19.9) (16.1) (21.4) (18.7) (24.1) 12.0 (31.8) (41.5) (52.4) (48.8) (35.9) (31.3) (22.6) (25.9) (6.7) (2.5) (1.7) 0
Key Metrics 2026 Q2 2026 Q1 2025 Q4 2025 Q3 2025 Q2 2025 Q1 2024 Q4 2024 Q3 2024 Q2 2024 Q1 2023 Q4 2023 Q3 2023 Q2 2023 Q1 2022 Q4 2022 Q3 2022 Q2 2022 Q1 2021 Q4 2021 Q3 2021 Q2 2021 Q1 2020 Q4 2020 Q3 2020 Q2 2020 Q1 2019 Q4
Income Statement
Revenue 0 0 5.5 0 2.0 2.3 2.0 1.8 1.1 3.4 3.6 4.7 2.4 4.7 2.5 0 0 0 0 0 0 0 0 0 0 0 0
Gross Profit 0 (0.3) 5.2 (0.3) 2.0 2.3 2.0 1.8 1.1 3.4 3.6 4.4 1.7 4.1 0.8 0 0 0 0 0 0 0 0 0 0 0 0
Operating Income (47.3) (43.5) (28.3) (34.0) (26.8) (21.4) (19.9) (25.9) (21.3) (24.3) (16.2) (15.6) (23.4) (16.6) (18.7) (25.5) (33.4) (49.7) (49.7) (50.7) (40.8) (32.1) (18.4) (15.0) (4.0) (5.6) (1.1)
Net Income (46.6) (42.4) (27.9) (32.7) (26.9) (21.5) (18.8) (25.5) (20.9) (24.1) 47.7 (117.1) (24.6) (17.6) (55.7) (26.5) (34.1) (50.3) (50.4) (51.2) (40.9) (32.0) (18.3) (15.0) (21.2) (5.4) (1.1)
EPS (Diluted) -0.13 -0.12 -0.08 -0.09 -0.09 -0.08 -0.09 -0.10 -0.09 -0.10 0.26 -0.93 -0.38 -0.28 -0.99 -0.65 -0.85 -1.32 -1.32 -1.35 -1.09 -0.87 -0.49 -1.28 -0.61 -0.36 -0.07
Balance Sheet
Cash & Equivalents 455.4 276.6 319.8 297.3 312.8 116.6 139.0 157.7 172.7 124.0 143.9 164.3 45.1 63.4 87.9 34.3 66.2 96.6 149.1 188.8 197.4 228.7 251.3 278.6 11.2
Total Assets 470.4 300.4 343.3 316.6 333.3 138.4 160.4 180.2 200.4 153.0 172.7 195.8 81.5 101.6 126.3 111.5 142.3 166.0 214.0 241.0 241.9 242.8 258.9 279.3 11.3
Total Debt 55.6 17.8 18.2 69.1 59.6 61.4 63.2 62.5 57.7 60.7 61.1 59.2 59.5 59.8 59.9 63.3 63.2 63.1 63.1 54.4 26.2 0 0 0 17.2
Stockholders' Equity 387.3 211.9 246.9 219.0 248.7 55.1 71.5 88.8 108.9 53.8 74.9 (49.1) (37.1) (14.9) 0.9 11.1 32.7 50.7 95.4 140.4 186.5 222.9 251.3 267.6 (8.8)
Cash Flow
Operating Cash Flow (40.4) (40.9) (26.7) (24.2) (20.2) (22.0) (18.3) (21.6) (21.5) (19.8) (16.1) (17.9) (18.8) (20.2) 14.3 (28.8) (33.4) (40.9) (40.3) (31.9) (22.8) (22.0) (19.8) (6.7) (2.5) (1.7) 0
Capital Expenditure 0.0 (3.0) (0.2) (0.1) (0.0) (0.4) 0.0 (0.0) (0.2) (0.1) (0.0) (3.5) 0.0 (3.9) (2.3) (3.0) (8.1) (11.4) (8.5) (4.0) (8.5) (0.5) (6.1) (0.0) 0 0 0
Free Cash Flow (40.4) (43.9) (27.0) (24.3) (20.2) (22.4) (18.3) (21.6) (21.7) (19.9) (16.1) (21.4) (18.7) (24.1) 12.0 (31.8) (41.5) (52.4) (48.8) (35.9) (31.3) (22.6) (25.9) (6.7) (2.5) (1.7) 0